Why Is DIEBOLD NIXDORF INC (DBD) Stock Down Today?

DBD stock fell 15.53% to $76.66 in early trading on July 29 after the company reported second-quarter results and reaffirmed its FY2026 guidance. The stock opened with a 2.7% gap down and continued to decline throughout the session, reaching a low of $76.62. The move follows recent insider selling and a weak intraday volume profile.

What Happened

Diebold Nixdorf reported Q2 2026 results with non-GAAP earnings per share of $1.10, in line with estimates, and revenue of $927.6 million, which beat expectations by $1.37 million. The company also reaffirmed its FY2026 guidance for adjusted EPS of $5.25 to $5.75 and revenue of $3.86 billion to $3.94 billion. Despite beating revenue estimates and growing adjusted EBITDA and net income, the stock declined sharply following the report. An SEC Form 8-K filed on July 29 disclosed the results and reaffirmed guidance.

Recent insider transactions have added to the sell pressure. Millstreet Capital Management LLC, a 10% shareholder, sold shares on June 12, June 24, and June 26. Over the past 90 days, insiders have executed three buys totaling $249,000 and five sells totaling $50 million. The most recent filing was on June 30.

What The Data Shows

The stock opened at $88.32, a 2.7% gap down from the prior close, and traded as low as $76.62 before settling at $76.66. Volume in the session reached 0.2 million shares, which is 0.4 times the 3-month average. The stock has a market cap of $3.1 billion, a P/E ratio of 30.9, and a beta of 1.11. Revenue has grown 4.3% in the trailing twelve months, while net margin stands at 2.8%. The 52-week range is $53.93 to $92.08.

What To Watch

The company is scheduled to release its full Q2 2026 earnings transcript in the coming days. Investors should monitor coverage breadth and any further insider transactions for signs of conviction in the stock’s direction.